GSK PLC American Depositary Shares (Each Representing Two Ordinary Shares) (GSK) closed at $49.51 on October 16, 2026, up 1.0% from the previous close, on volume of 6,147,698 shares (30-day average 4,399,899).
Data as of October 16, 2026.
16-Oct-2026
UBS Keeps Their Hold Rating on GlaxoSmithKline (GSK)
TipRanks (Thu, 15-Oct 8:06 AM ET)
GlaxoSmithKline (GSK) Receives a Buy from Berenberg Bank
TipRanks (Wed, 14-Oct 8:25 AM ET)
AM Markets Need to Know: Trump Eyes Greenland Resources, Microsoft Cuts Costs, and more
Seeking Alpha News (Wed, 14-Oct 6:03 AM ET)
GSK plans more than 1,200 job cuts in Belgium
Seeking Alpha News (Wed, 14-Oct 5:37 AM ET)
GlaxoSmithKline (GSK) Gets a Sell from Barclays
TipRanks (Wed, 14-Oct 2:45 AM ET)
GSK taps Viola Davis for “Shingles, actually” campaign as it targets the 50+ risk gap
Market Chameleon (Thu, 8-Oct 3:58 AM ET)
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
PRNewswire (Thu, 8-Oct 7:40 AM ET)
PRNewswire (Mon, 24-Aug 1:06 PM ET)
Market Chameleon (Tue, 28-Jul 3:32 AM ET)
New survey reveals Canadians underestimate chronic hepatitis B and its link to liver cancer
PRNewswire (Tue, 28-Jul 7:00 AM ET)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
GSK PLC American Depositary Shares (Each Representing Two Ordinary Shares) trades on the NYSE stock market under the symbol GSK.
As of October 16, 2026, GSK stock price climbed to $49.51 with 6,147,698 million shares trading.
GSK has a beta of 0.11, meaning it tends to be less sensitive to market movements. GSK has a correlation of 0.00 to the broad based SPY ETF.
GSK has a market cap of $99.24 billion. This is considered a Large Cap stock.
Last quarter GSK PLC American Depositary Shares (Each Representing Two Ordinary Shares) reported $11 billion in Revenue and $1.35 earnings per share. This beat revenue expectation by $490 million and exceeded earnings estimates by $.08.
In the last 3 years, GSK traded as high as $61.70 and as low as $31.72.
The top ETF exchange traded funds that GSK belongs to (by Net Assets): AVDE, FENI, PPH, FVD, GMOI.
GSK has outperformed the market in the last year with a price return of +17.3% while the SPY ETF gained +16.7%. However, in the short term, GSK had mixed performance relative to the market. It has underperformed in the last 3 months, returning -5.3% vs +1.9% return in SPY. But in the last 2 weeks, GSK shares have fared better than the market returning +5.3% compared to SPY -0.8%.
GSK support price is $48.28 and resistance is $49.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GSK shares will trade within this expected range on the day.
